{
  "folder": "IC-223",
  "content": "{{knowledge objective\n|Identifiant=OIC-223-01-A\n|Item_parent=Dyslipidaemia\n|Item_parent_short=Dyslipidemia\n|Rank=A\n|Title=Knowing how to assess global cardiovascular risk\n|Description=None\n|Rubric=Definition\n|Contributors=Laurence Duvillard, Bruno Verg\u00e8s, Benjamin Bouillet, Laurence Amar, Christian Boissier, Tristan Mirault, Claire Le Hello\n|Order=1}}\n<br />[[File:SCORE2 et SCORE2-OP.jpg|vignette|746x746px|SCORE2 et SCORE2-OP]]\n\n==Cardiovascular risk assessment using multifactorial equations==\nThe European equations SCORE2 (Systematic COronary Risk Evaluation) and SCORE2-OP (older people)\n\n*are based on serum non-HDL cholesterol concentration, smoking habits, systolic blood pressure, age and sex,\n*assess the 10-year risk of coronary ischaemia or stroke, fatal or non-fatal.\n*are valid only in subjects aged \u226540 and <70 years for SCORE2 and subjects aged \u226570 years for SCORE2-OP.\n*not used in cases of diabetes, chronic renal failure, familial hypercholesterolaemia or known atheromatous pathology.\n\n{| class=\"wikitable\"\n|+Assessment of the 10-year risk of cardiovascular mortality in \"apparently\" healthy individuals, i.e. without renal insufficiency, diabetes, genetic familial dyslipidaemia or established cardiovascular disease.\n!\n!< 50 years\n!50-69 years\n!\u2265 70 years\n|-\n!low to moderate risk\n|<2,5%\n|<5%\n|<7,5%\n|-\n!high risk\n|\u22652,5 \u00e0 <7,5%\n|\u22655 \u00e0 <10%\n|\u22657,5 \u00e0 <15%\n|-\n!very high risk\n|\u22657,5%\n|\u226510%\n|\u226515%\n|}\nIf the SCORE2 or SCORE2-OP equations are not used, the level of risk may be assessed pragmatically by summing the traditional risk factors (SFE-SFD-NSFA consensus, 2016):\n\n*Age (\u2265 50 years in men, \u2265 60 years in women)\n*Family history of ischaemic cardiovascular disease (\u2264 55 years in father or first-degree relative, \u2264 60 years in mother or first-degree relative).\n*Smoking (current or stopped less than 3 years ago), [[Male/female smoking 2C-075-PE-A02]]\n*Arterial hypertension, [[Arterial hypertension SD-042]]\n*HDLc \u2264 1.0 mmol/L [\u22640.4 g/L ]\n\nRisk level:\n\n*low: 0 or 1 cardiovascular risk factor\n*moderate: 2 cardiovascular risk factors\n*high: \u2265 3 cardiovascular risk factors\n*very high: history of cardiovascular disease (secondary prevention)\n\n==Special situations==\n\n*Patients with chronic renal failure in adults and children.\n**Patients with type 2 or type 1 diabetes (SFD/SFC 2021 consensus: Diabetes Metab. 2021 Mar;47(2):101185)s,[[Diabetes mellitus types 1 and 2 in children and adults. Complications]]\n\n{| class=\"wikitable\"\n!\n! chronic renal failure\n!Type 2 diabetes or Type 1 diabetes\n|-\n!low to moderate risk\n|eDFG \u226560mL/min/1.73m\u00b2 + ACR < 30mg/mmol\neDFG 45-59mL/min/1.73m\u00b2 + ACR < 3mg/mmol\n|Type 2 diabetes < 10 years or type 1 diabetes < 20 years, controlled, no target organ damage, no other cardiovascular risk factors.\n|-\n!high risk\n|eDFG \u226560mL/min/1.73m\u00b2 + ACR \u2265 30mg/mmol\n\neDFG 45-59mL/min/1.73m\u00b2 + ACR 3-30 mg/mmol\n\neDFG 30-44mL/min1.73m\u00b2 + ACR < 3mg/mmol\n|At least 2 of the following criteria:\n\n*Type 2 diabetes for \u2265 10 years or type 1 diabetes for \u2265 20 years\n*Early family history of coronary heart disease (M<50 years, F<60 years)\n*uncontrolled cardiovascular risk factors (HbA1c, LDL cholesterol, blood pressure, smoking)\n*ACR > 3mg/mmol or eDFG < 60mL/min/1.73m\u00b2.\n*Severe retinopathy or vegetative neuropathy or erectile dysfunction\n*Low physical activity\n|-\nVery high risk\n|eDFG < 30mL/min/1.73m\u00b2 *Severe retinopathy or vegetative neuropathy or erectile dysfunction\neDFG 30-44mL/min1.73m\u00b2 + ACR \u2265 3mg/mmol\n|At least 1 of the following criteria:\n\n*Proven cardiovascular disease including atrial fibrillation eDFG < 30mL/min/1.73m\u00b2 regardless of RTA\n*ACR > 30mg/mmol\n*LDL-c > 4.9 mmol/L (i.e. 1.9 g/L) on treatment\n*Q waves on ECG\n*Left ventricular abnormalities on echocardiography\n*Peripheral arterial stenosis \u226550%.\n|}\nACR: albumin to creatinine ratio (to go from mg/mmol to mg/g multiply by 10); eDFG: estimated glomerular filtration rate; HbA1c: glycated haemoglobin, M: male; F: female; LDL-c: LDL cholesterol; ECG: electrocardiogram.\n\n*Patients with familial hypercholesterolaemia, who are at high risk from the outset.\n*Patients with \"proven cardiovascular disease\", all of whom are at very high risk and have either\n**either symptomatic atheromatous disease defined by at least one history of\n***ischaemic stroke\n***transient ischaemic stroke\n***myocardial infarction\n***acute coronary syndrome\n***coronary revascularisation and any other arterial revascularisation\n***abdominal aortic aneurysm\n***peripheral arterial disease: subclavian arteries, renal arteries, digestive arteries, arteries of the lower limbs\n**or asymptomatic atheromatous disease documented by imaging:\n***coronary plaque\n***carotid plaque\n\n*Prescription of a hypolipidemic agent SD-252]], Prescription of insulin therapy, follow-up consultation and education for a type 1 diabetic patient SD-280]], Prescription of medication, follow-up consultation and education for a type 2 diabetic patient or a patient with secondary diabetes SD-281]], [Drug prescription, follow-up consultation and education for a hypertensive patient SD-282]], [[Follow-up consultation and therapeutic education for a patient with a history of cardiovascular disease SD-285]], [[Follow-up of a patient with chronic renal failure SD-290]], [[Prevention of cardiovascular disease SD-320]]",
  "question": {
    "question": "What is the risk level for a patient with chronic renal failure, type 2 diabetes for \u226510 years, uncontrolled cardiovascular risk factors, and an ACR > 3mg/mmol?",
    "option_a": "low",
    "option_b": "moderate",
    "option_c": "high",
    "option_d": "very high",
    "correct_option": "very high"
  }
}